A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.


Updates from The Motley Fool

Latest updates on Osiris Therapeutics from Fool.com.


Stock Performance

OSIR vs. S&P 500 | 2 Year Performance
View Interactive OSIR Charts
Sponsored by

Key Data Points

Primary metrics and data points about Osiris Therapeutics.
Current Price: $4.78
Prev Close: $4.89
Open: $4.80
Bid: $4.75
Ask: $5.98
Day's Range: $4.75 - $4.86
52wk Range: $3.55 - $19.44
Volume: 55,055
Avg Vol 56,796
Market Cap: $164.68M
P/E (ttm): 97.80
EPS (ttm): $0.05
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Osiris Therapeutics.
CAPS Rating 1 out of 5
 
148 Outperform
67 Underperform
CAPS All Stars
 
33 Outperform
31 Underperform

How do you think Osiris Therapeutics will perform against the market?



You pick for Osiris Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Charles Mills, CEO

19% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Osiris Therapeutics.

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers